Granules India Limited — Important, 29-01-2025: General Updates

Granules India has received the EU GMP certificate for its Unit V facility in Anakapally, Visakhapatnam, which manufactures Active Pharmaceutical Ingredients (APIs) and Finished Dosages (FDs). The certification, awarded by the National Centre for Public Health and Pharmacy in Hungary, follows an audit conducted in November 2024. This certification enhances the company's capabilities in producing oncology and non-oncology products and positions it for potential growth in European markets. Investors should watch closely for this development, as it could strengthen Granules India's competitive stance and open new business opportunities.